Organization | Finnish Cultural Foundation

Finnish Cultural Foundation Report issue

Foundation Phase 2 Phase 4

Founded: Helsinki Finland (1939)

Organization Overview

First Clinical Trial

2006

NCT01742702

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2012

Timeline

NOW

Now

Alternative names

Finnish Cultural Foundation

Active Ingredients

Drugs in Phase 4 Trials (2)

pentastarch (Pentaspan) (1 trial)

sodium chloride (1 trial)

Drugs in Phase 2 Trials (1)

atorvastatin (lipitor) (1 trial)

Drugs in Other Trials (7)

albuterol (proventil) (1 trial)

arginine (1 trial)

bisoprolol (zebeta) (1 trial)

nitroglycerin (transderm-nitro) (1 trial)

small milk casein-derived polypeptides (1 trial)

uralenic acid (1 trial)

vitamin d3 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Prostatic Neoplasms (Phase 2)

Overview

Highest Phase: Phase 4
# of Trials: 4
# of Trial APIs: 10